Inhibition of Platelet-Activating Factor (PAF) Acetylhydrolase by Methyl Arachidonyl Fluorophosphonate Potentiates PAF Synthesis in Thrombin-Stimulated Human Coronary Artery Endothelial Cells
Authors:
- Michael H. CreerMCMichael H. Creer
- Kimberley N. CrownKCKimberley N. Crown
- Karin WirsigKWKarin Wirsig
- Jane McHowatJMJane McHowat
- 1 December 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 307 (3) , 1163-1170
Abstract
We have previously demonstrated that thrombin stimulation of endothelial cells results in increased membrane-associated, Ca2+-independent phospholipase A2 (iPLA2) activity, accelerated hydrolysis of membrane plasmalogen phospholipids, and production of several biologically active phospholipid metabolites, including prostacyclin and platelet-activating factor (PAF) that is abolished by pretreatment with the iPLA2-selective inhibitor bromoenol lactone. This study was designed to further investigate the role of alternative PLA2 inhibitors, including methyl arachidonyl fluorophosphonate (MAFP, an inhibitor of cytosolic PLA2 isoforms), on phospholipid turnover and PAF production from thrombin-stimulated human coronary artery endothelial cells (HCAECs). Paradoxically, pretreatment of HCAEC with MAFP (5–25 μM) resulted in a significant increase in PAF production in both unstimulated and thrombin-stimulated cells that was found to be a direct result of inhibition of PAF acetylhydrolase (PAF-AH) activity. Pretreatment with MAFP did not significantly inhibit HCAEC PLA2 activity, possibly due to the localization of PLA2 activity in the membrane fraction rather than the cytosol. Bromoenol lactone did not inhibit PAF-AH activity, even at concentrations as high as 20 μM. We conclude that MAFP augments thrombin-stimulated PAF production by inhibition of PAF catabolism without affecting membrane-associated iPLA2 activity.Keywords
This publication has 32 references indexed in Scilit:
- Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophilsEuropean Journal of Biochemistry, 2002
- Regulation of VEGF‐induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathwaysBritish Journal of Pharmacology, 2001
- Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A2: structure-function studies with vesicle, micelle, and membrane assays1This paper is dedicated to the memory of Prof. H.M. Verheij.1Biochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonistBritish Journal of Pharmacology, 1997
- Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidaseBiochemical Pharmacology, 1997
- Bromoenol Lactone Inhibits Magnesium-dependent Phosphatidate Phosphohydrolase and Blocks Triacylglycerol Biosynthesis in Mouse P388D1 MacrophagesJournal of Biological Chemistry, 1996
- Distinct Roles in Signal Transduction for Each of the Phospholipase A2 Enzymes Present in P388D1 MacrophagesJournal of Biological Chemistry, 1996
- Platelet-activating Factor Acetylhydrolase Increases during Macrophage DifferentiationJournal of Biological Chemistry, 1989
- Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959